Home>
US Stocks>
Emergent Biosolutions

Emergent Biosolutions share price today

(EBS)

Emergent Biosolutions share price is $8.1 & ₹688.31 as on 21 Dec 2024, 2.30 'hrs' IST

$8.1

▲

0.04

(0.5%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Emergent Biosolutions share price in Dollar and Rupees. Guide to invest in Emergent Biosolutions from India. Also see the sentimental analysis on Indian investors investing in Emergent Biosolutions. Get details on the Indian mutual funds that are investing in Emergent Biosolutions. Get Analyst recommendations and forecasts along with all the Emergent Biosolutions's financials.

Emergent Biosolutions share price movements

Today's Low: $7.83
Today's High: $8.35
$8.10
3.33%
Downside
Day's Volatility :6.23%
Upside
2.99%
52 Weeks Low: $1.42
52 Weeks High: $15.10
$8.10
82.47%
Downside
52 Weeks Volatility :90.6%
Upside
46.36%

Emergent Biosolutions Returns

Period	Emergent Biosolutions Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	33.66%	-11.1%	0.0%
6 Months	19.65%	-6.0%	0.0%
1 Year	226.61%	2.7%	0.0%
3 Years	-81.88%	0.6%	-19.7%

Emergent Biosolutions Key Statistics

in dollars & INR

Previous Close	$8.06
Open	$7.85
Today's High	$8.35
Today's Low	$7.83
Market Capitalization	$540.2M
Today's Volume	$2.4M
52 Week High	$15.1
52 Week Low	$1.42
Revenue TTM	$1.1B
EBITDA	$-4.8M
Earnings Per Share (EPS)	$-11.22
Profit Margin	-18.55%
Quarterly Earnings Growth YOY	0.02%
Return On Equity TTM	-34.64%

How to invest in Emergent Biosolutions from India?

It is very easy for Indian residents to invest directly in Emergent Biosolutions from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Emergent Biosolutions stock in both Indian Rupees (INR) and US Dollars (USD). Search for Emergent Biosolutions or EBS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Emergent Biosolutions or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Emergent Biosolutions shares which would translate to 0.105 fractional shares of Emergent Biosolutions as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Emergent Biosolutions, in just a few clicks!

Returns in Emergent Biosolutions for Indian investors in Rupees

Investment Value

₹1,00,000

Emergent Biosolutions investment value today

Current value as on today

₹3,28,809

Returns

₹2,28,809

(+228.81%)

Returns from Emergent Biosolutions Stock

₹2,26,613 (+226.61%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Emergent Biosolutions

-16%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Emergent Biosolutions on INDmoney from India has reduced in the last 30 days as on Dec 21, 2024. -16% less investors are searching Emergent Biosolutions in the last 30 days versus the previous period.

Global Institutional Holdings in Emergent Biosolutions

BlackRock Inc
7.09%
Vanguard Group Inc
6.27%
Marshall Wace Asset Management Ltd
4.60%
Charles Schwab Investment Management Inc
4.11%
State Street Corp
3.53%
American Century Companies Inc
3.20%

Analyst Recommendation on Emergent Biosolutions

Sell

11%Buy

22%Hold

66%Sell

Based on 9 Wall street analysts offering stock ratings for Emergent Biosolutions(by analysts ranked 0 to 5 stars)

Based on 9 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Emergent Biosolutions

What analysts predicted

Upside of 48.15%

Current:

$8.10

Target:

$12.00

Insights on Emergent Biosolutions

Price Movement
In the last 1 year, EBS stock has moved up by 253.7%
Increasing Revenue
Revenue is up for the last 2 quarters, 254.7M → 293.8M (in $), with an average increase of 13.3% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -283.1M → 114.8M (in $), with an average increase of 346.6% per quarter

Emergent Biosolutions Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$782.4M	↑ 39.5%
Net Income	$62.7M	↓ 24.09%
Net Profit Margin	8.01%	↓ 6.72%

	FY19	Y/Y Change
Revenue	$1.1B	↑ 41.36%
Net Income	$54.5M	↓ 13.08%
Net Profit Margin	4.93%	↓ 3.08%

	FY20	Y/Y Change
Revenue	$1.6B	↑ 40.63%
Net Income	$305.8M	↑ 461.1%
Net Profit Margin	19.66%	↑ 14.73%

	FY21	Y/Y Change
Revenue	$1.8B	↑ 15.26%
Net Income	$219.5M	↓ 28.22%
Net Profit Margin	12.24%	↓ 7.42%

	FY22	Y/Y Change
Revenue	$1.1B	↓ 37.47%
Net Income	$-223.8M	↓ 201.96%
Net Profit Margin	-19.97%	↓ 32.21%

	FY23	Y/Y Change
Revenue	$1.0B	↓ 6.39%
Net Income	$-760.5M	↑ 239.81%
Net Profit Margin	-72.48%	↓ 52.51%

	Q2 FY23	Q/Q Change
Revenue	$337.9M	↑ 104.66%
Net Income	$-261.3M	↑ 42.79%
Net Profit Margin	-77.33%	↑ 33.51%

	Q3 FY23	Q/Q Change
Revenue	$270.5M	↓ 19.95%
Net Income	$-265.9M	↑ 1.76%
Net Profit Margin	-98.3%	↓ 20.97%

	Q4 FY23	Q/Q Change
Revenue	$276.6M	↑ 2.26%
Net Income	$-49.5M	↓ 81.38%
Net Profit Margin	-17.9%	↑ 80.4%

	Q1 FY24	Q/Q Change
Revenue	$300.4M	↑ 8.6%
Net Income	$9.0M	↓ 118.18%
Net Profit Margin	3.0%	↑ 20.9%

	Q2 FY24	Q/Q Change
Revenue	$254.7M	↓ 15.21%
Net Income	$-283.1M	↓ 3245.56%
Net Profit Margin	-111.15%	↓ 114.15%

	Q3 FY24	Q/Q Change
Revenue	$293.8M	↑ 15.35%
Net Income	$114.8M	↓ 140.55%
Net Profit Margin	39.07%	↑ 150.22%

	FY18	Y/Y Change
Profit	$460.1M	↑ 26.0%

	FY19	Y/Y Change
Profit	$672.5M	↑ 46.16%

	FY20	Y/Y Change
Profit	$1.0B	↑ 53.37%

	FY21	Y/Y Change
Profit	$1.0B	↑ 0.37%

	FY22	Y/Y Change
Profit	$427.2M	↓ 58.73%

	FY23	Y/Y Change
Profit	$343.9M	↓ 19.5%

	Q2 FY23	Q/Q Change
Profit	$147.3M	↑ 1373.0%

	Q3 FY23	Q/Q Change
Profit	$93.7M	↓ 36.39%

	Q4 FY23	Q/Q Change
Profit	$74.8M	↓ 20.17%

	Q1 FY24	Q/Q Change
Profit	$139.4M	↑ 86.36%

	Q2 FY24	Q/Q Change
Profit	$-54.5M	↓ 139.1%

	Q3 FY24	Q/Q Change
Profit	$171.2M	↓ 414.13%

	FY18	Y/Y Change
Operating Cash Flow	$41.8M	↓ 79.92%
Investing Cash Flow	$-897.2M	↑ 258.98%
Financing Cash Flow	$788.7M	↓ 1634.41%

	FY19	Y/Y Change
Operating Cash Flow	$188.0M	↑ 349.76%
Investing Cash Flow	$-96.9M	↓ 89.2%
Financing Cash Flow	$-35.9M	↓ 104.55%

	FY20	Y/Y Change
Operating Cash Flow	$536.0M	↑ 185.11%
Investing Cash Flow	$-151.0M	↑ 55.83%
Financing Cash Flow	$69.5M	↓ 293.59%

	FY21	Y/Y Change
Operating Cash Flow	$321.1M	↓ 40.09%
Investing Cash Flow	$-225.0M	↑ 49.01%
Financing Cash Flow	$-141.0M	↓ 302.88%

	FY22	Y/Y Change
Operating Cash Flow	$-34.1M	↓ 110.62%
Investing Cash Flow	$-381.3M	↑ 69.47%
Financing Cash Flow	$481.2M	↓ 441.28%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-114.4M	↓ 37.83%
Investing Cash Flow	$257.7M	↓ 1806.62%
Financing Cash Flow	$-486.9M	↑ 4537.14%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$60.0M	↓ 152.45%
Investing Cash Flow	$-18.9M	↓ 107.33%
Financing Cash Flow	$-43.0M	↓ 91.17%

Emergent Biosolutions Technicals Summary

Sell

Neutral

Buy

Emergent Biosolutions is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Emergent Biosolutions Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Emergent Biosolutions Inc	-13.83%	19.65%	226.61%	-81.88%	-85.26%
Neurocrine Biosciences Inc.	8.34%	1.35%	5.43%	59.49%	24.91%
Haleon Plc Spon Ads	1.47%	12.15%	18.9%	30.77%	30.77%
Zoetis Inc.	-6.72%	-4.07%	-15.46%	-31.76%	24.53%
Viatris Inc.	-5.51%	19.58%	17.56%	-5.51%	-23.38%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Emergent Biosolutions Inc	69.58	NA	1.55	-1.15	-0.35	-0.04	NA	9.4
Neurocrine Biosciences Inc.	35.99	35.99	0.32	6.54	0.16	0.12	NA	26.87
Haleon Plc Spon Ads	28.53	28.53	1.73	0.34	0.07	0.04	0.02	1.82
Zoetis Inc.	30.68	30.68	2.6	5.88	0.47	0.15	0.01	11.59
Viatris Inc.	224.4	NA	0.07	2.69	-0.04	0.02	0.04	16.58

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Emergent Biosolutions Inc	Sell	$540.2M	-85.26%	69.58	-18.55%
Neurocrine Biosciences Inc.	Buy	$13.7B	24.91%	35.99	17.21%
Haleon Plc Spon Ads	Buy	$44.1B	30.77%	28.53	10.75%
Zoetis Inc.	Buy	$73.8B	24.53%	30.68	26.55%
Viatris Inc.	Hold	$14.5B	-23.38%	224.4	-5.87%

About Emergent Biosolutions

emergent biosolutions is a global life sciences company dedicated to one simple mission—to protect and enhance life. we develop, manufacture, and deliver a portfolio of medical countermeasures for biological and chemical threats as well as emerging infectious diseases. through our work, we envision protecting and enhancing 50 million lives with our products by 2025. additional information about the company may be found at www.emergentbiosolutions.com. follow us @emergentbiosolu and @life_at_emergent

Organization	Emergent Biosolutions
Employees	1600
CEO	Mr. Richard S. Lindahl M.B.A.
Industry	Health Technology

Management People of Emergent Biosolutions

Name	Title
Mr. Richard S. Lindahl M.B.A.	Executive VP, CFO & Treasurer
Ms. Coleen Glessner	Executive Vice President of Global Quality and Ethics & Compliance
Mr. Paul A. Williams	Senior Vice President of Products Business
Mr. Joseph C. Papa Jr.	CEO, President & Director
Ms. Jessica Perl	Senior VP, Corporate Secretary & General Counsel
Ms. Michelle Pepin	Senior VP & Chief Human Resource Officer
Ms. Stephanie Duatschek	Senior VP, Chief Strategy & Transformation Officer
Mr. William Hartzel	Senior Vice President of Manufacturing & Bioservices
Mr. Simon C. Lowry M.D.	Chief Medical Officer & Head of Research and Development

Important FAQs about investing in Emergent Biosolutions from India :

What is Emergent Biosolutions share price today?

Emergent Biosolutions share price today stands at $8.10, Open: $7.85 ; Previous Close: $8.06 ; High: $8.35 ; Low: $7.83 ; 52 Week High: $15.10 ; 52 Week Low: $1.42. The stock opens at $7.85, after a previous close of $8.06. The stock reached a daily high of $8.35 and a low of $7.83, with a 52-week high of $15.10 and a 52-week low of $1.42.

Can Indians buy Emergent Biosolutions shares?

Yes, Indians can invest in the Emergent Biosolutions (EBS) from India.

With INDmoney, you can buy Emergent Biosolutions at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Emergent Biosolutions at zero transaction cost.

How can I buy Emergent Biosolutions shares from India?

It is very easy to buy Emergent Biosolutions from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Emergent Biosolutions be purchased?

Yes, you can buy fractional shares of Emergent Biosolutions with INDmoney app.

What are the documents required to start investing in Emergent Biosolutions stocks?

To start investing in Emergent Biosolutions, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.